Table 1.
PPALN* N = 118 |
PLN** N = 139 |
P value | |
---|---|---|---|
Age | |||
Mean (SD) | 63.1 (10.7) | 67.1 (9.5) | 0.002 |
Histology | |||
Grade 3 endometrioid | 52 (44.4%) | 33 (23.7%) | 0.002 |
Papillary serous | 23 (19.7%) | 45 (32.4%) | |
Clear cell | 9 (7.7%) | 15 (10.8%) | |
Grade 2 endometrioid | 4 (3.4%) | 2 (1.4%) | |
Mixed | 25 (21.4%) | 43 (30.9%) | |
Stage | |||
I | 66 (55.9%) | 74 (53.2%) | 0.33 |
II | 7 (5.9%) | 12 (8.6%) | |
III | 35 (29.7%) | 33 (23.7%) | |
IV | 10 (8.5%) | 20 (14.4%) | |
Lymphovascular invasion | |||
No | 52 (47.7%) | 83 (64.8%) | 0.008 |
Yes | 57 (52.3%) | 45 (35.2%) | |
Myometrial invasion | |||
No | 60 (52.6%) | 88 (64.7%) | 0.05 |
Yes | 54 (47.4%) | 48 (35.3%) | |
Intraoperative complications | |||
None | 99 (86.1%) | 124 (89.9%) | 0.44 |
1 or more | 16 (13.9%) | 14 (10.1%) | |
Postoperative complications | |||
None | 54 (46.6%) | 79 (57.2%) | 0.09 |
1 or more | 62 (53.4%) | 59 (42.8%) |
*Pelvic and para-aortic lymph node group.
**Pelvic lymph node group.